Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Henneman

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2022
Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed GlioblastomaMyra E van Linde, Mariette Labots, Cyrillo G Brahm, et al.
Molecular Oncology|October 6, 2020
Optimized low-dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatmentMarloes Zoetemelk, George M Ramzy, Magdalena Rausch, et al.
Molecular & Cellular Proteomics : MCP|April 5, 2025
CellEKT: A Robust Chemical Proteomics Workflow to Profile Cellular Target Engagement of Kinase InhibitorsJoel Rüegger, Berend Gagestein, Antonius P A Janssen, et al.
Basic Research in Cardiology|June 19, 2025
The innate immune receptor NLRX1 is a novel required modulator for mPTP opening: implications for cardioprotectionY Xiao, X Hu, C F Rudolphi, et al.
Cancer Cell|May 30, 2025
The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targetsJaco C Knol, Mengge Lyu, Franziska Böttger, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2022
Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed GlioblastomaMyra E van Linde, Mariette Labots, Cyrillo G Brahm, et al.
Molecular Oncology|October 6, 2020
Optimized low-dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatmentMarloes Zoetemelk, George M Ramzy, Magdalena Rausch, et al.
Molecular & Cellular Proteomics : MCP|April 5, 2025
CellEKT: A Robust Chemical Proteomics Workflow to Profile Cellular Target Engagement of Kinase InhibitorsJoel Rüegger, Berend Gagestein, Antonius P A Janssen, et al.
Basic Research in Cardiology|June 19, 2025
The innate immune receptor NLRX1 is a novel required modulator for mPTP opening: implications for cardioprotectionY Xiao, X Hu, C F Rudolphi, et al.
Cancer Cell|May 30, 2025
The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targetsJaco C Knol, Mengge Lyu, Franziska Böttger, et al.
Pageof 9